Pharmaceutical companies tend to say a cancer drug costs $2.7billion But that highly-criticized figure was gathered from private data sets Now a study has found the average is actually around $650million Cancer drugs do not cost as much to produce as industry-sponsored research claims, according to a landmark analysis. Pharmaceutical companies often say it costs...
Category: <span>Pharmaceutical Updates</span>
Post
Type 2 diabetics should take aspirin TWICE a day to prevent heart disease: Finding contradicts guidelines that recommend the anti-clotting drug once every 24 hours
When taken once a day, the risk of blood clots between doses is substantial Researchers advise taking the drug twice in a day to reduce clots between doses Participants who did not previously take aspirin were more at-risk of clotting Blood clots can lead to cardiovascular disease, such as heart attacks and stroke The researchers...
Post
Cells programmed like computers to fight disease
This is a figure showing RNA sequence of command. Led by Professor Alfonso Jaramillo in the School of Life Sciences, new research has discovered that a common molecule — ribonucleic acid (RNA), which is produced abundantly by humans, plants and animals — can be genetically engineered to allow scientists to program the actions of a...
Post
Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology. The results are being presented today by the University at Buffalo researcher who led the study at...
Post
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes. Principal results were published today in the New England Journal of Medicine of a global Phase 3 clinical trial in patients with type 1 diabetes treated with sotagliflozin. Sotagliflozin is an investigational...
Post
Danish discovery can pave the way for more effective cholesterol medicine
More than 600,000 Danes are being treated with cholesterol lowering medicine. 98 per cent of them are treated with statins, which curb the body’s own production of cholesterol so that the level of cholesterol falls. However, statins also give rise to the body forming more of a harmful protein – known as PCSK9 – which...
Post
Skin patch dissolves ‘love handles’ in mice
Microneedle skin patch that delivers fat-shrinking drug locally could be used to treat obesity and diabetes Microneedle patch. Researchers have devised a medicated skin patch that can turn energy-storing white fat into energy-burning brown fat locally while raising the body’s overall metabolism. The patch could be used to burn off pockets of unwanted fat such...
Post
This New Vaccine Technology Could Make Multiple Injections a Thing of the Past
IN BRIEF Researchers from MIT have developed a new way of delivering multiple vaccine doses in just one injection using a new drug-carrying particle. Designing the particles themselves required an equally innovative solution that used 3D fabrication. SEALED AND TIMED Nobody enjoys getting a shot; especially when you have to get more than one. Currently,...
Post
ASBMR: Romosozumab reduces fracture rate in osteoporosis
(HealthDay)—Romosozumab treatment followed by alendronate is linked to reduced risk of fractures versus alendronate alone for postmenopausal women with osteoporosis, according to a study published online Sept. 11 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the American Society for Bone and Mineral Research, held from...
Post
Therapy proves effective in subgroup of COPD patients
MILAN, ITALY, Sept. 12, 2017 – An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in...